Overexpression of type 1 angiotensin II receptors impairs excitation-contraction coupling in the mouse heart.

@article{Rivard2011OverexpressionOT,
  title={Overexpression of type 1 angiotensin II receptors impairs excitation-contraction coupling in the mouse heart.},
  author={Katy Rivard and Scott A. Grandy and Annie Douillette and Pierre Paradis and Mona Nemer and Bruce G. Allen and C{\'e}line Fiset},
  journal={American journal of physiology. Heart and circulatory physiology},
  year={2011},
  volume={301 5},
  pages={
          H2018-27
        }
}
  • K. Rivard, S. Grandy, +4 authors C. Fiset
  • Published 19 August 2011
  • Biology
  • American journal of physiology. Heart and circulatory physiology
Transgenic mice that overexpress human type 1 angiotensin II receptor (AT(1)R) in the heart develop cardiac hypertrophy. Previously, we have shown that in 6-mo AT(1)R mice, which exhibit significant cardiac remodeling, fractional shortening is decreased. However, it is not clear whether altered contractility is attributable to AT(1)R overexpression or is secondary to cardiac hypertrophy/remodeling. Thus the present study characterized the effects of AT(1)R overexpression on ventricular L-type… 

Figures and Tables from this paper

Changes in Systolic and Diastolic Function in a Mouse Model Overexpressing Cardiac Angiotensin II AT-1 Receptor
TLDR
In conclusion, cardiac-specific AT1R overexpression induces systolic and diastolic ventricular dysfunction which is completely reversed by At1R blockade, independent of left ventricular mass changes.
Sildenafil Does Not Prevent Heart Hypertrophy and Fibrosis Induced by Cardiomyocyte Angiotensin II Type 1 Receptor Signaling
TLDR
It is found that even a prolonged SIL treatment regimen did not limit the progressive CM growth, fibrosis, or decline in cardiac functions in the αMHC-AT1Rtg/+ model, suggesting that SIL does not interfere with the pathogenic actions of amplified AT1R signaling in CMs.
Angiotensin II Overstimulation Leads to an Increased Susceptibility to Dilated Cardiomyopathy and Higher Mortality in Female Mice
TLDR
It is suggested that females are more susceptible to the adverse effects of AT1R stimulation than males favouring the development of HF and increased mortality, and may have more severe eccentric hypertrophy, dysfunction and compromised Ca2+ dynamics.
Ageing-related cardiomyocyte functional decline is sex and angiotensin II dependent
TLDR
Sexual dimorphic functional effects of ageing combined with angiotensin II (AngII) on cardiac muscle cell function, twitch and Ca2+-handling characteristics of isolated cardiomyocytes from young and aged mice support the contention that sex-specific therapies are required for the treatment of age-progressive heart failure.
A state of reversible compensated ventricular dysfunction precedes pathological remodelling in response to cardiomyocyte-specific activity of angiotensin II type-1 receptor in mice
TLDR
It is shown that chronic HART activity in young adult mice causes ventricular dysfunction without hypertrophy, fibrosis or cardiomyocyte death, and that a state of pre-hypertrophic compensated dysfunction can exist in affected individuals before common markers of heart disease are detectable.
MK2-deficient mice are bradycardic and display delayed hypertrophic remodelling in response to a chronic increase in afterload
TLDR
Results implicate MK2 in autonomic regulation of heart rate, cardiac mitochondrial function, and the early stages of myocardial remodeling in response to chronic pressure overload.
Investigating Angiotensin II in cardiac remodelling and the counter-regulatory actions of Angiotensin-(1-9)
TLDR
The main aim of this thesis was to assess the effects of chronic Ang-(1-9) administration on cardiac structure and function in a model of Ang II-induced cardiac remodelling and investigate novel pathways contributing to the pathological remodelling in response to Ang II.
Transient Neonatal High Oxygen Exposure Leads to Early Adult Cardiac Dysfunction, Remodeling, and Activation of the Renin–Angiotensin System
TLDR
Transient neonatal O2 exposure in rats leads to left ventricular hypertrophy, fibrosis and dysfunction, and increased susceptibility to heart failure under pressure overload, which is relevant to the growing population of individuals born preterm who may be at higher risk of cardiac dysfunction when faced with increased peripheral resistance associated with hypertension, vascular diseases, and aging.
...
1
2
3
...

References

SHOWING 1-10 OF 50 REFERENCES
Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.
TLDR
A direct myocardial role for AII is demonstrated in the development of cardiac hypertrophy and failure and transgenic mice provide a useful model to elucidate the mechanisms of action of AII in the pathogenesis of cardiac diseases.
Cardiac-specific overexpression of the human type 1 angiotensin II receptor causes delayed repolarization.
TLDR
It is suggested that chronic stimulation of AT1R directly leads to an increased incidence of cardiac arrhythmia associated with delayed repolarization and ventricular arrhythmias.
Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide receptor (GC-A) deficient mice
TLDR
Chronic hypertension in GC-A−/− mice is associated with progressive cardiac changes—namely, initially compensated cardiomyocyte hypertrophy, which is complicated by interstitial fibrosis and impaired cardiac contractility at later stages.
Angiotensin II–Mediated Phenotypic Cardiomyocyte Remodeling Leads to Age-Dependent Cardiac Dysfunction and Failure
TLDR
Investigation of phenotypic changes in cardiomyocytes during the adaptive response to chronic cardiac-specific endogenous Ang II stimulation concluded that chronic Ang II myocardial stimulation without hemodynamic overload is sufficient to produceCardiomyocyte and cardiac dysfunction culminating in heart failure.
Angiotensin II–Mediated Adaptive and Maladaptive Remodeling of Cardiomyocyte Excitation–Contraction Coupling
TLDR
It is suggested that chronic elevation of cardiac Ang II levels significantly alters cardiomyocyte ECC in the long term, and thereby contractility, independently of hemodynamic overload and arterial hypertension.
Angiotensin II type 1 receptor blockade prevents diastolic heart failure through modulation of Ca(2+) regulatory proteins and extracellular matrix.
TLDR
Long-term AT(1)R blockade prevented the development of diastolic heart failure through attenuation of left ventricular relaxation abnormality and myocardial stiffening without a reduction in blood pressure.
Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK.
TLDR
The results showed that the NIE of ANG II was not associated with a parallel decrease in the intracellular Ca2+ transient, indicating that a decrease in myofilament responsiveness to Ca2+, which underlies the reduction in contractility.
Angiotensin II‐dependent loss of cardiac function: Mechanisms and pharmacological targets attenuating this effect
TLDR
The study identified a paracrine mechanism for the Ang II‐dependent loss of cardiac function that occurs independently of hemodynamic changes and characterized the differences between Ang II and α‐adrenoceptor stimulation with respect to the maintenance of cellular function explaining cellular events contributing to the difference between adaptive (physiological) and mal‐adaptive (patho‐physiological] hypertrophy.
Effects of angiotensin II subtype 1 receptor blockade on cardiac fibrosis and sarcoplasmic reticulum Ca2+ handling in hypertensive transgenic rats overexpressing the Ren2 gene
TLDR
Normalization of LV SR Ca2+ uptake is an important mechanism by which AT1receptor antagonism improves LV diastolic dysfunction independent from a reduction of SBP and cardiac fibrosis in the TGR (mRen2)27 model.
...
1
2
3
4
5
...